,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1434978,155094,Comparative Toxicogenomics Database (CTD),6-Prenylnaringenin,C521871,6-prenylnaringenin,https://ctdbase.org/detail.go?type=chem&acc=C521871,196,AHR,https://ctdbase.org/detail.go?type=gene&acc=196,,,196,AHR,9606,Homo sapiens (human),6-prenylnaringenin results in increased activity of AHR protein,,,PMID:30608650,https://www.ncbi.nlm.nih.gov/pubmed/30608650,30608650,,
1,1435161,155094,Comparative Toxicogenomics Database (CTD),6-Prenylnaringenin,C521871,6-prenylnaringenin,https://ctdbase.org/detail.go?type=chem&acc=C521871,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543,CYP1A1,9606,Homo sapiens (human),6-prenylnaringenin inhibits the reaction [DNMT1 protein binds to CYP1A1 promoter]|6-prenylnaringenin inhibits the reaction [estradiol promotes the reaction [DNMT1 protein binds to CYP1A1 promoter]]|6-prenylnaringenin results in increased expression of CYP1A1 protein|6-prenylnaringenin inhibits the reaction [estradiol results in decreased expression of CYP1A1 mrna],,,PMID:32986415,https://www.ncbi.nlm.nih.gov/pubmed/32986415,32986415,,
2,1435162,155094,Comparative Toxicogenomics Database (CTD),6-Prenylnaringenin,C521871,6-prenylnaringenin,https://ctdbase.org/detail.go?type=chem&acc=C521871,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543,CYP1A1,9606,Homo sapiens (human),6-prenylnaringenin results in increased expression of CYP1A1 mRNA,,,PMID:27269377|PMID:32986415,https://www.ncbi.nlm.nih.gov/pubmed/27269377|https://www.ncbi.nlm.nih.gov/pubmed/32986415,27269377|32986415,,
3,1435163,155094,Comparative Toxicogenomics Database (CTD),6-Prenylnaringenin,C521871,6-prenylnaringenin,https://ctdbase.org/detail.go?type=chem&acc=C521871,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545,CYP1B1,9606,Homo sapiens (human),6-prenylnaringenin results in increased expression of CYP1B1 mRNA,,,PMID:27269377,https://www.ncbi.nlm.nih.gov/pubmed/27269377,27269377,,
4,1435164,155094,Comparative Toxicogenomics Database (CTD),6-Prenylnaringenin,C521871,6-prenylnaringenin,https://ctdbase.org/detail.go?type=chem&acc=C521871,1786,DNMT1,https://ctdbase.org/detail.go?type=gene&acc=1786,,,1786,DNMT1,9606,Homo sapiens (human),6-prenylnaringenin inhibits the reaction [DNMT1 protein binds to CYP1A1 promoter]|6-prenylnaringenin inhibits the reaction [estradiol promotes the reaction [DNMT1 protein binds to CYP1A1 promoter]],,,PMID:32986415,https://www.ncbi.nlm.nih.gov/pubmed/32986415,32986415,,
5,1435165,155094,Comparative Toxicogenomics Database (CTD),6-Prenylnaringenin,C521871,6-prenylnaringenin,https://ctdbase.org/detail.go?type=chem&acc=C521871,2099,ESR1,https://ctdbase.org/detail.go?type=gene&acc=2099,,,2099,ESR1,9606,Homo sapiens (human),Benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [6-prenylnaringenin results in decreased expression of ESR1 protein]|6-prenylnaringenin promotes the reaction [estradiol results in decreased expression of ESR1 protein]|2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [6-prenylnaringenin results in decreased expression of ESR1 protein]|6-prenylnaringenin results in decreased expression of ESR1 protein,,,PMID:32986415,https://www.ncbi.nlm.nih.gov/pubmed/32986415,32986415,,
6,1455746,155094,IUPHAR/BPS Guide to PHARMACOLOGY,6-Prenylnaringenin,12585,6-prenylnaringenin,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=12585,535,Cav3.1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=535,O43497,Voltage-dependent T-type calcium channel subunit alpha-1G,8913,CACNA1G,9606,Homo sapiens (human),Antagonist,pIC50,6.0,PMID:30031654,https://www.ncbi.nlm.nih.gov/pubmed/30031654,30031654,,
